60 Degrees Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for 60 DEGREES PHARMS
60 DEGREES PHARMS has one approved drug.
There are four US patents protecting 60 DEGREES PHARMS drugs.
There are nine patent family members on 60 DEGREES PHARMS drugs in eight countries.
Summary for 60 Degrees Pharms
| International Patents: | 9 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for 60 Degrees Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60 Degrees Pharms | ARAKODA | tafenoquine succinate | TABLET;ORAL | 210607-001 | Aug 8, 2018 | RX | Yes | Yes | 10,342,791 | ⤷ Start Trial | ⤷ Start Trial | ||||
| 60 Degrees Pharms | ARAKODA | tafenoquine succinate | TABLET;ORAL | 210607-001 | Aug 8, 2018 | RX | Yes | Yes | 10,888,558 | ⤷ Start Trial | ⤷ Start Trial | ||||
| 60 Degrees Pharms | ARAKODA | tafenoquine succinate | TABLET;ORAL | 210607-001 | Aug 8, 2018 | RX | Yes | Yes | 12,616,689 | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for 60 Degrees Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 107683278 | ⤷ Start Trial |
| Australia | 2015358566 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2016089995 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
